My Biocon Biologicsᵀᴹ provides FULPHILA® patient access support
A team of dedicated patient access specialists is available to answer calls and address concerns or questions regarding:
Coverage & claim
- Verify appeal requirements
- Track status and resolution of appeals
Alternate Coverage Identification
- My Biocon Biologics can help identify other resources, such as state programs or third-party charitable foundations, that may be able to assist your patients
Insurance coverage verification
- Check patient insurance plan enrollment status
Benefit Investigation
- Research patient-specific insurance coverage, coding, and billing requirements for FULPHILA and its administration
- Verify patient cost-sharing requirements including deductible, co-pay, coinsurance, and out-of-pocket maximum, and amounts met to date
- Determine payer access requirements (eg, specialty pharmacy, in-office dispensing, etc)
- Prepare Summary of Benefits that documents all findings
Patient Enrollment
- For full terms and conditions Click Here
- Download/Fax Enrollment form
Prior Authorization (PA) / Reauthorization Assistance & Tracking
- Check PA requirements, submission details, and track status
- Provide offices with payer-specific forms
Billing & Coding
- Provide information about applicable coding for FULPHILA (pegfilgrastim-jmdb) and its administration.
- Click here to access the Coding and Billing Guide for Fulphila.
Note: Coding information is provided for informational purposes only and the physician must determine the appropriate code for each patient and payer
Experienced and caring My Biocon Biologics
patient access specialists are available
-
Monday-Friday
9:00 am to 8:00 pm ET - Phone: 1 (833) 695-2623
- Fax: 1 (833) 247-2756
- Patient support services and resources are available 24 hours a day, 7 days a week, via the My Biocon Biologics portal at www.mybioconbiologicsportal.com
References:
- Fulphila® (pegfilgrastim-jmdb) injection. Prescribing information. 2023. Biocon Biologics Inc. Cambridge, MA.
-
U.S. Food and Drug Administration. Biosimilars. Available at:
https://www.fda.gov/drugs/developmentapprovalprocess/howdrugsaredevelopedandapproved/approvalapplications/therapeuticbiologicapplications/biosimilars/default.htm
Accessed on: 10 August 2023. - Vogel C, et al. J Clin Oncol. 2005;23:1178-1184.
- Waller, C.F., Ranganna, G.M., Pennella, E.J. et al. Ann Hematol. (2019) 98: 1217.